Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow-to-Debt Ratio
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2023, meaning its operating cash flow of €56.11 Million could theoretically repay 0% of its total liabilities (€3.22 Billion) in one year. See XIN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Xinhua Pharmaceutical Company Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. For the full cash flow conversion analysis, see XIN operating cash flow.
Annual Cash Flow-to-Debt Ratio for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year debt coverage analysis for Shandong Xinhua Pharmaceutical Company Limited. Check Shandong Xinhua Pharmaceutical Company L (XIN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €533.73 Million | €3.73 Billion | ▲ +48.0% |
| 2024 | 0.10x | €367.61 Million | €3.80 Billion | ▲ +27.9% |
| 2023 | 0.08x | €265.28 Million | €3.51 Billion | ▼ -61.0% |
| 2022 | 0.19x | €758.24 Million | €3.92 Billion | ▲ +175.1% |
| 2021 | 0.07x | €259.12 Million | €3.68 Billion | ▼ -38.0% |
| 2020 | 0.11x | €420.19 Million | €3.70 Billion | ▲ +8.4% |
| 2019 | 0.10x | €348.27 Million | €3.33 Billion | ▲ +0.9% |
| 2018 | 0.10x | €323.91 Million | €3.12 Billion | ▼ -28.3% |
| 2017 | 0.14x | €389.97 Million | €2.69 Billion | ▼ -12.9% |
| 2016 | 0.17x | €439.35 Million | €2.64 Billion | ▲ +19.6% |
| 2015 | 0.14x | €348.64 Million | €2.51 Billion | ▼ -6.4% |
| 2014 | 0.15x | €346.34 Million | €2.33 Billion | ▲ +200.6% |
| 2013 | 0.05x | €104.99 Million | €2.13 Billion | — |